Pfizer, Atavistik
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics: Cambridge, Massachusetts Friday, January 3, 2025, 15:00
This partnership could redefine precision medicine with groundbreaking therapeutics targeting "impossible" proteins.
Atavistik Bio Inc. has entered into a research collaboration with Pfizer Inc. to accelerate the discovery of novel precision allosteric therapeutics for unmet medical needs. Under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback